<Disease><Name>27-HYDROXYLASE DEFICIENCY (CTX)</Name><Synonym>CEREBROTENDINOUS XANTHOMATOSIS; CTX</Synonym><OMIM><Number>213700</Number><URL>http://omim.org/entry/213700</URL></OMIM><Orphanet><Number>909</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=909</URL></Orphanet><Protein><Number>Sterol 27-hydroxylase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q02318</URL></Protein><ExPASy><Number>1.14.13.15</Number><URL>http://enzyme.expasy.org/EC/1.14.13.15</URL></ExPASy><Gene>2q35</Gene><ICD>E75.5</ICD><Summary>rare (&gt;300 cases);autosomal recessive;mutations in the cytochrome P450 CYP27A1 gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2327</id><symptom>atherosclerosis</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3460</id><symptom>cognitive impairment / cognitive dysfunction</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3848</id><symptom>gait disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2488</id><symptom>myocardial infarction, myocardial ischemia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1972</id><symptom>paraparesis/paraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4016</id><symptom>paresis</symptom><category>MUSCLES</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3992</id><symptom>pes cavus</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2143</id><symptom>respiratory insufficiency / respiratory failure</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3172</id><symptom>xanthoma</symptom><category>SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>1081</id><name>27-Hydroxylase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1080</id><name>Cholestanol</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>normal/increased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>normal/increased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>normal/increased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>normal/increased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>normal/increased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>8029</id><title>Multi-imaging study in a patient with cerebrotendinous xanthomatosis: radiology, clinic and pathology correlation of a rare condition</title><author>DellAversano Orabona G,</author><journal>BJR Case Rep</journal><year>2020</year><book /><volume>6</volume><number>1</number><pages>10190047</pages><co_aut>et al.</co_aut></literature><literature><id>8030</id><title>A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis</title><author>Tang Y,</author><journal>Int J Neurosci</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6033</id><title>Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain st</title><author>Del Mar Amador M,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5400</id><title>Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)</title><author>Salen G,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Steiner RD</co_aut></literature><literature><id>5405</id><title>Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis</title><author>Stelten BML,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3262</id><title>[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypica</title><author>Lionnet C,</author><journal>Rev Neurol (Paris) [Article in French]</journal><year>2014</year><book /><volume>170</volume><number>0</number><pages>445-453</pages><co_aut>et al.</co_aut></literature><literature><id>3263</id><title>[Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics]</title><author>Preiss Y,</author><journal>Rev Med Chil [Article in Spanish]</journal><year>2014</year><book /><volume>142</volume><number>5</number><pages>616-622</pages><co_aut>et al.</co_aut></literature><literature><id>3050</id><title>Cerebrotendinous xanthomatosis: a rare disorder with a rare presentation</title><author>Agrawal NK,</author><journal>BMJ Case Rep</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Garg S</co_aut></literature><literature><id>2806</id><title>Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat</title><author>Berginer VM,</author><journal>Pediatrics</journal><year>2009</year><book /><volume>123</volume><number>1</number><pages>143-147</pages><co_aut>et al.</co_aut></literature><literature><id>2596</id><title>Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?</title><author>Siman-Tov T</author><journal>J Neurol Sci</journal><year>2006</year><book /><volume>243</volume><number>0</number><pages>83-86</pages><co_aut>et al.</co_aut></literature><literature><id>2597</id><title>Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized</title><author>Lorincz MT</author><journal>Arch Neurol</journal><year>2005</year><book /><volume>62</volume><number>9</number><pages>1459-1463</pages><co_aut>et al.</co_aut></literature><literature><id>2598</id><title>Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy</title><author>von Bahr S</author><journal>J Pediatr Gastroenterol Nutr</journal><year>2005</year><book /><volume>40</volume><number>4</number><pages>481-486</pages><co_aut>et al.</co_aut></literature><literature><id>1350</id><title>Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy</title><author>Federico A</author><journal>J Child Neurol</journal><year>2003</year><book /><volume>18</volume><number>9</number><pages>633-638</pages><co_aut>Dotti MT</co_aut></literature><literature><id>1554</id><title>Cholestanol metabolism, molecular pathology, and nutritional implications</title><author>Seyama Y</author><journal>J Med Food</journal><year>2003</year><book /><volume>6</volume><number>3</number><pages>217-224</pages><co_aut /></literature><literature><id>1555</id><title>Cerebrotendinous xanthomatosis, a treatable metabolic disorder</title><author>Heller R</author><journal>Nervenarzt</journal><year>2002</year><book /><volume>73</volume><number>12</number><pages>1160-1166</pages><co_aut>et al.</co_aut></literature><literature><id>1556</id><title>Cerebrotendinous xanthomatosis: molecular characterization of two Scandinavian sisters</title><author>Rystedt E</author><journal>J Intern Med</journal><year>2002</year><book /><volume>252</volume><number>3</number><pages>259-264</pages><co_aut>et al.</co_aut></literature><literature><id>1557</id><title>Paradoxical enhancement of hepatic metabolism of 7-ketocholesterol in sterol 27-hydroxylase-deficient mice</title><author>Lyons MA</author><journal>Biochim Biophys Acta</journal><year>2002</year><book /><volume>1581</volume><number>3</number><pages>119-126</pages><co_aut>Maeda N, Brown AJ</co_aut></literature><literature><id>2595</id><title>Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis</title><author>Clayton PT</author><journal>J Inherit Metab Dis</journal><year>2002</year><book /><volume>25</volume><number>6</number><pages>501-513</pages><co_aut>et al.</co_aut></literature><literature><id>1349</id><title>Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans</title><author>Bjorkhem I</author><journal>Trends Endocrinol Metab</journal><year>2000</year><book /><volume>11</volume><number>5</number><pages>180-183</pages><co_aut>Leitersdorf E</co_aut></literature><literature><id>374</id><title>Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol</title><author>Bj+&#194;rkhem I</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2073-2099</pages><co_aut>Boberg KM</co_aut></literature><literature><id>381</id><title>Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis and sitosterolemia with xanthomatosis</title><author>Salen G</author><journal>in Stanburry JB, Wyngaarden JB, Fredrickson DS, Brown MS, Goldstein JL (eds):Metabolic Basis of inherited disease, 5/e; ; McGraw-Hill Inc.</journal><year>1989</year><book /><volume>0</volume><number>0</number><pages>713</pages><co_aut>Shefer S, Berginer VM</co_aut></literature></Literatures></Disease>